Keyphrases
Taspase1
100%
Her2neu
100%
Cyclin
100%
Breast Tumorigenesis
100%
MLL1
100%
Mixed-phenotype Acute Leukemia
38%
MMTV-Neu
30%
Mammary Gland
15%
Cyclin A
15%
HER2-positive Breast Cancer
15%
Cyclin E
15%
Knockdown
7%
Breast Cancer Cell Lines
7%
Therapeutic Target
7%
In Vitro Study
7%
Breast Cancer
7%
Transgenic Mice
7%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Biological Processes
7%
Normal Development
7%
Breast Cancer Cells
7%
Protease
7%
Threonine
7%
Cancer Cell Lines
7%
Tumorigenesis
7%
Human Breast Cancer
7%
Cleavable
7%
Transcriptional Regulator
7%
Tumor Formation
7%
Mouse Embryonic Fibroblasts
7%
Mammary Tumorigenesis
7%
Physiology of Pregnancy
7%
HER2-positive
7%
BT-474
7%
Mouse Mammary Gland
7%
E2F Transcription Factor 1 (E2F1)
7%
MCF10A Cells
7%
MLL2
7%
Cyclin B
7%
TFIIA
7%
Breast Cancer Pathology
7%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Proliferating Cell Nuclear Antigen
100%
Mouse Mammary Tumor Virus
100%
HER2/neu
100%
Cancer Cell
42%
Cyclin A
28%
Cyclin E
28%
In Vitro Study
14%
Transgenic Mouse
14%
Allele
14%
Biological Phenomena and Functions Concerning the Entire Organism
14%
MLL2
14%
Transcription Factor E2F
14%
Cyclin B
14%
Threonine Protease
14%
Fibroblast
14%
Development
14%
Immunology and Microbiology
Cycline
100%
HER2/neu
100%
Mouse Mammary Tumor Virus
100%
Lineages
71%
Mammary Gland
42%
Cyclin E
28%
Cyclin A
28%
Transgenic Mouse
14%
Allele
14%
Cancer Cell
14%
Biological Phenomena and Functions Concerning the Entire Organism
14%
Cancer Cell Line
14%
Breast Cancer Cell Line
14%
Cyclin B
14%
Transcription Factor E2F
14%
Fibroblast
14%
Development
14%
Threonine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
100%
Cycline
100%
Mouse Mammary Tumor Virus
100%
Leukemia
71%
Breast Cancer
42%
Cyclin E
28%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
28%
Cyclin A
28%
Malignant Neoplasm
14%
Transgenic Mouse
14%
Proteinase
14%
Threonine
14%
Transcription Factor E2F
14%
Cyclin B
14%